May 12, 2021 / 05:15PM GMT
Alec Warren Stranahan - BofA Securities, Research Division - Associate
Hey, everyone. Good afternoon, and welcome to Day 3 of the BofA Healthcare Conference. Thanks for joining this session with MeiraGTx. My name is Alec Stranahan, I'm the analyst covering Meira here at BofA. And I'm pleased to be joined by Zandy Forbes, President and Chief Executive Officer of Meira.
And I believe Zandy is going to run through a few prepared remarks to start off, and then we'll jump into Q&A. So with that, Zandy, over to you.
Alexandria Forbes - MeiraGTx Holdings plc - CEO, President & Director
Thank you, Alex (sic) [Alec]. Zandy Forbes, CEO of Meira, and I'm going to give a very brief overview of the strategy as well as the capabilities and pipeline at Meira, just a couple of minutes.
We are a company that was formed not just to address rare inherited diseases with gene therapy, although we do have a pipeline of rare inherited diseases, clinical and preclinical in collaboration with Janssen. We also focus on other diseases which are not inherited,
MeiraGTx Holdings PLC at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 12, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers